用药物涂层的气球为De Novo急性心肌梗塞的干预
Ae-Young Her1, Sunwon Kim2, Dong Oh Kang3
1Division of Cardiology, Department of Internal Medicine, Kangwon National University College of Medicine, Kangwon National University School of Medicine, Chuncheon, Korea.
Yonsei medical journal
|November 25, 2025
概括
对急性心肌梗塞 (AMI) 的药物涂层气球 (DCB) 治疗显示出比药物释放支架 (DES) 更好的结果. 在两年内,DCB PCI显著减少了AMI患者的主要不良心血管事件,再血管化和出血.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 生物材料在医学中的应用
背景情况:
- 有限的数据存在于药物涂层气球 (DCB) 在急性心肌梗塞 (AMI) 的使用.
- 穿皮冠状动脉干预 (PCI) 是对AMI的标准治疗方法.
- 药物排泄支架 (DES) 常用于PCI,但正在探索替代方案.
研究的目的:
- 评估DCB再血管化的疗效和安全性与传统PCI与第二代DES相比,在新发AMI的患者中.
- 评估长期的临床结果,包括净不良心血管事件 (NACE),目标血管再血管化和重大出血.
主要方法:
- 对329名新发性AMI患者进行了回顾性分析,这些患者接受了基于DCB的PCI治疗.
- 倾向性得分匹配与使用注册表中的DES进行传统PCI的患者进行比较.
- 两年后续,将DCB和DES组之间的NACE利率进行比较.
主要成果:
- 与仅使用DES的PCI相比,2年后,基于DCB的PCI显示NACE的累积发病率显著降低 (6.2%对10.8%),目标血管再血管 (1.7%对5.7%) 和严重出血 (0.8%对3.2%) 与仅使用DES的PCI相比.
- 这些发现在各种统计调整方法中是一致的,包括多变量回归,倾向得分匹配和治疗权重的逆概率.
- 基于DCB的PCI独立地与降低2年NACE风险,目标血管再血管化和重大出血有关.
结论:
- 与传统的DES-onlyPCI相比,基于DCB的PCI在2年随访时在新发性AMI患者中表现出优异的临床结果.
- 基于DCB的PCI代表了一种安全有效的替代方案,用于选择的AMI患者,具有最佳的前扩张.
- 进一步的前性研究可能会证实这些发现,并确定DCB作为新发性AMI的主要治疗选择.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
203
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
203
Coronary Artery Disease V: Interprofessional Care
206
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
206
Angina IV: Management
222
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
222
Acute Coronary Syndrome I: Introduction
744
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
744
Peripheral Artery Disease III: Interprofessional Care
229
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
229
Acute Coronary Syndrome III: Diagnostic Studies
200
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
200


